Baron Silver Stevens Financial Advisors, LLC Astrazeneca PLC Transaction History

Baron Silver Stevens Financial Advisors, LLC

$587 Million
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 27, 2021	SELL	$47.16 - $54.44 $3,867 - $4,464	-82 Closed	0 $0
Q4 2020 Mar 19, 2021	BUY	$48.52 - $58.02 $3,978 - $4,757	82 New	82 $4,000

Others Institutions Holding AZN

# of Institutions

1,334

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.42 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.95 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.62 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.59 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.34 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baron Silver Stevens Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baron Silver Stevens Financial Advisors, LLC with notifications on news.

Account